Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Obucaine hydrochloride is a local anesthetic of the ester type, historically used primarily in ophthalmology for topical anesthesia of the eye. It works by blocking sodium channels on neuronal membranes, thereby inhibiting nerve impulse conduction and producing localized loss of sensation. Obucaine is structurally related to other ester-type local anesthetics such as procaine and cocaine but has been largely replaced in clinical practice by safer and more effective agents like lidocaine due to its potential for toxicity and allergic reactions. Its primary indication was short-term surface anesthesia during minor ocular procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on obucaine hydrochloride.